Susan Bressman, MD Email Susan Bressman
- SITE CHAIR, NEUROLOGY, MOUNT SINAI BETH ISRAEL, MOUTH SINAI ROOSEVELT | Mount Sinai St. Luke's
- PROFESSOR | Neurology
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Brooklyn
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai Doctors Faculty Practice 212-844-8379 212-844-8379
Susan B. Bressman, MD holds the Alan and Joan Mirken Chair and is the Mount Sinai Health System Vice - Chair for the Department of Neurology and Chair for the Departments of Neurology at Mount Sinai Beth Israel and Mount Sinai West; she is also a Professor of Neurology at the Icahn School of Medicine. She is recognized for her work identifying genes and characterizing phenotypes, including the identification of dystonia genes, as well as Parkinson’s disease genotype phenotype studies. Her current research is focused on identifying diagnostic and progression markers and disease pathways for Parkinson’s disease, especially the LRRK2 and GBA genetic subtypes. She also continues to work on gene identification for dystonia, tremor and other movement disorders.
Dr Bressman attended Columbia University’s College of Physicians and Surgeons and received her postgraduate and fellowship training at Columbia’s Neurological Institute. She has authored more than 200 articles in peer-reviewed journals, is a co-editor of two books, and has been named by Castle Connolly, New York Magazine, and The New York Times as a Best Doctor. In 2014 Castle Connolly recognized her with their Physician of the Year Award for Clinical Excellence. She was a Director of the American Academy of Neurology and associate editor for Movement Disorders, and has served or serves on the scientific advisory boards of the Michael J. Fox Foundation for Parkinson’s Research, Bachmann-Strauss Dystonia and Parkinson’s Disease Foundation, and Dystonia Medical Research Foundation.
Dr. Bressman offers telemedicine appointments when appropriate. Please call her office to schedule a video visit.
Neurology, American Board of Psychiatry and Neurology
- Benign Essential Tremor
- Botulinum Toxin Injections
- Cervical Dystonia
- Huntington's Disease
- Lewy Body Disease
- Movement Disorders
- Multiple System Atrophy
- Parkinson's Disease
- Restless Legs Syndrome
- Tardive Dyskinesia
MD, Columbia University College of Physicians & Surgeons
Internship, Internal Medicine
Weill Cornell Medical College
Fellowship, Movement Disorders
Honorary Membership Award
International Parkinson and Movement Disorder Society
For extraordinary contribution to the field of Movement Disorders
Movement Disorder Research Award
American Academy of Neurology
Recognition of research contribution to the field
Bachman Strauss Prize
Michael J. Fox Foundation
In recognition of excellence in dystonia research
Stanley Fahn Lectureship
The Movement Disorder Society
in recognition of outstanding clinical research
Dystonia and Parkinson's Disease
I am a Director of the Mount Sinai Health System Movement Disorders Center and the Mirken Family Professor of Neurology. Over the last 30 years, my research has focused on identifying etiologies and disease mechanisms, especially genetic, that underlie dystonia (TORIA, THAP1, GNAL, GCH1, SGCE) and Parkinson’s disease (LRRK2, GBA ). My unique contribution has been in helping to create and promote translational teams and my special expertise has been clinical characterization and family studies aimed at identifying relatively homogeneous subgroups likely to share etiologies. As an extension of this work, once genetic etiologies are identified I have pursued further translational research aimed at expanding understanding of gene expression; this includes using additional clinical testing, imaging, and biomarkers of pathology. My work has been supported by the NIH, Michael J Fox Foundation, Dystonia Medical research Foundation and Bachmann Strauss Dystonia and Parkinson’s Foundation.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Bressman during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Denali Therapeutics
- Michael J. Fox Foundation
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Internationational Parkinson
- Michael J. Fox Foundation
- Mount Sinai (NY)
Scientific Advisory Board:
- Michael J. Fox Foundation
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.